drugset / Trial / NCT03702621

Comparing Liposomal Bupivacaine Versus Standard Bupivacaine in Colorectal Surgery

NCT03702621

Phase 3 Completed 90 enrolled Indiana University
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the difference between two different pain control methods in patients who will be having a colorectal surgery

Timeline

Start
2018-08-30
Primary completion
2020-03-13
Completion
2020-03-13

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 40 ml
Comparator Bupivacaine Other / unclassified 60 ml
Comparator Bupivacaine Other / unclassified 266 mg

Indications